FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

Go back to FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.30 -0.02 (6.25%)
Previous Close $0.32    52 Week High $31.32 
Open $0.31    52 Week Low $13.95 
Day High $0.32    P/E N/A 
Day Low $0.30    EPS $-3.29 
Volume 4,104,851